Glycated low density lipoproteins alter vascular reactivity in hyperlipidemic hyperglycemic hamsters

Annals of the Romanian Society for Cell Biology

Volumn 17, Issue 1, 2012, Pages 9-15

  Stancu, Camelia Sorina ^a,b   Georgescu, Adriana ^a,c   Toma, Laura ^a   Sanda, Gabriela Maria ^a   Sima, Anca Volumnia ^a  

^a INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY NICOLAE SIMIONESCU   (Romania)

^b Institute for Economic Forecasting   (Romania)

^c PETRU PONI INSTITUTE OF MACROMOLECULAR CHEMISTRY   (Romania)

Author keywords

AGE LDL; Hamster; Hyperglycemia; Hyperlipidemia; Vascular reactivity

Indexed keywords

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS;

EID: 84864352395     PISSN: 15836258     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bartuoe, M.; Lomnicka, M.; Lorkowska, B.; Franczyk, M.; Kostogrys, R.B.; Pisulewski, P.M.; Chopicki, S.: Hypertriglyceridemia but not hypercholesterolemia induces endothelial dysfunction in the rat. Pharmacol. Rep., 57, Suppl. 127-137, 2005
2. Campbell, N.R.C.; Gilbert, R.E.; Leiter, L.A.; Larochelle, P.; Tobe, S.; Chockalingam, A.; Ward, R.; Morris, D.; Tsuyuki, R.T.; Harris, S.B.: Hypertension in people with type 2 diabetes-Update on pharmacologic management. Can. Fam. Physician., 57, 997-1002, 2011
3. Cohen, J.D.: Overview of Physiology, Vascular Biology, and Mechanisms of Hypertension. J. Manag. Care Pharm., 13, 5, S6-S8, 2007
4. Cohen, M.P.; Ziyadeh, F.N.; Chen, S.: Amadori modified glycated serum proteins and accelerated atherosclerosis in diabetes: pathogenic and therapeutic implications. J. Lab. Clin. Med., 147, 211-9, 2006
5. Doran, A.C.; Meller, N.; McNamara, C.A.: Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 28, 812-819, 2008.
6. Georgescu, A.; Popov, D.: Age-dependent accumulation of advanced glycation endproducts is accelerated in combined hyperlipemia and hyperglycemia, a process attenuated by L-Arginine. J. Am. Aging Assoc., 23, 33-40, 2000
7. Georgescu, A.; Alexandru, N.; Constantinescu, E.; Popov, D.: Effect of gap junction uncoupler heptanol on resistance arteries reactivity in experimental models of diabetes, hyperlipemia and hyperlipemia-diabetes. Vascul. Pharmacol., 44, 513-518, 2006
8. Georgescu, A.; Popov, D.; Dragan, E.; Dragomir, E.; Badila, E.: Protective effects of nebivolol and reversal of endothelial dysfunction in diabetes associated with hypertension. Eur. J. Pharmacol., 570, 149-158, 2007
9. Ismail, H.; Makaryus, A.N.: Management of hypertension in patients with coronary artery disease. Expert Rev. Cardiovasc. Ther., 9, 10, 1271-77, 2011
10. Israili, Z.H.; Hernandez-Hernandez, R.; Valasco, M.: The future of antihypertensive treatment. Am. J. Ther., 14, 121-134, 2007
11. Krishnamurti, U.; Rondeau, E.; Sraer, J.D.; Michael, A.F.; Tsilibary, E.C.: Alterations in human glomerular epithelial cells interacting with nonenzymatically glycosylated matrix. J. Biol. Chem., 272, 27966-27970, 1997
12. Mulvany, M.J.; Halpern, W.: Contractile properties of small arteriolar resistance vessels in spontaneously hypertensive and normotensive rats. Circ. Res., 41, 19-26, 1977
13. Nistor, A.; Simionescu, M.: Uptake of low density lipoproteins by the hamster lung. Interactions with 15 capillary endothelium. Am. Rev. Respir. Dis., 134, 1266-1272, 1986
14. Nivoit, P.; Wiernsperger, N.; Moulin, P.; Lagarde, M.; Renaudin, C.: Effect of glycated LDL on microvascular tone in mice: a comparative study with LDL modified in vitro or isolated from diabetic patients. Diabetologia, 46, 1550-1558, 2003
15. Okon, E.B.; Chung, A.W.; Zhang, H.; Laher, I.; van Breemen, C.: Hyperglycemia and hyperlipidemia are associated with endothelial dysfunction during the development of type 2 diabetes. Can. J. Physiol. Pharmacol., 85, 5, 562-567, 2007
16. Shiu, S.W.; Tan, K.C.; Wong, Y.; Leng, L.; Bucala, R.: Glycoxidized LDL increases lectin-like oxidized low density lipoprotein receptor-1in diabetes mellitus. Atherosclerosis., 203, 522-527, 2009
17. Sima, A.V.; Stancu, C.S.; Simionescu M.: Vascular endothelium in atherosclerosis, Cell. Tissue. Res., 335, 191-203, 2009
18. Sima, A.V.; Botez, G.M.; Stancu, C.S.; Manea, A.; Raicu, M.; Simionescu, M.: Effect of irreversibly glycated LDL in human vascular smooth muscle cells: lipid loading, oxidative and inflammatory stress. J. Cell. Mol. Med., 14, 2790-2802, 2010.
19. Simionescu, M.; Popov, D.; Sima, A.; Hasu, M.; Costache, G.; Faitar, S.; Vulpanovici, A.; Stancu, C.; Stern, D.; Simionescu, N.: Pathobiochemistry of combined diabetesand atherosclerosis studied on a novel animal model. The hyperlipemic- hyperglycemic hamster. Am. J. Pathol., 148, 997-1014, 1996
20. Stitt, A.W.; He, C.; Friedman, S.; Scher, L.; Rossi, P.; Ong, L.; Founds, H.; Li, Y.M.; Bucala, R.; Vlassara, H.: Elevated AGE-modified ApoB in sera of euglycemic, normolipidemic patients with atherosclerosis: relationship to tissue AGEs. Mol. Med., 3, 617-627, 1997
21. Toma, L.; Stancu, C.S.; Botez, G.M.; Sima, A.V.; Simionescu, M.: Irreversibly glycated LDL induce oxidative and inflammatory state in human endothelial cells; added effect of high glucose. Biochem. Biophys. Res. Commun., 390, 877-882, 09
22. Toma, L.; Stancu, C.S.; Sanda, G.M.; Sima, A.V.: Anti-oxidant and anti-inflammatory mechanisms of amlodipine action to improve endothelial cell dysfunction induced by irreversibly glycated LDL. Biochem. Biophys. Res. Commun., 411, 202-7, 2011
23. Xiang, L.; Dearman, J.; Abram, S.R.; Carter, C.; Hester, R.L.: Insulin resistance and impaired functional vasodilation in obese Zucker rats. Am. J. Physiol. Heart. Circ. Physiol., 294, H1658-H1666, 8
24. Younis, N.,; Sharma, R.; Soran, H.; Charlton-Menys, V.; Elseweidy, M.; Durrington, P.N.: Glycation as an atherogenic modification of LDL. Curr. Opin. Lipidol., 19, 378-84, 2008.